CLBT Stock Recent News

TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2025 financial results before market open on Wednesday, May 14, 2025.

The premier evening celebrated the best and brightest in digital investigations, kicking off the Company's inaugural sold out Case-to-Closure User Summit for 700+ attendees The premier evening celebrated the best and brightest in digital investigations, kicking off the Company's inaugural sold out Case-to-Closure User Summit for 700+ attendees

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission (the “SEC”).

Investors looking for stocks in the Technology Services sector might want to consider either Smiths Group PLC (SMGZY) or Cellebrite DI Ltd. (CLBT). But which of these two companies is the best option for those looking for undervalued stocks?

Cellebrite DI Ltd. (CLBT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it.

In this video, Anand Chokkavelu, Travis Hoium, and Lou Whiteman discuss Cellebrite (CLBT -5.53%), a key player in digital forensics for law enforcement. They provide ratings and insights on its growth potential, management, and financials, helping you decide if this stock is a worthy investment.

Cellebrite DI Ltd. (NASDAQ:CLBT ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Andrew Kramer - IR Tom Hogan - Interim CEO Dana Gerner - CFO Marcus Jewell - CRO Ronnen Armon - Chief Products and Technology Officer Conference Call Participants Shaul Eyal - TD Cowen Bhavin Shah - Deutsche Bank Eric Martinuzzi - Lake Street Charlotte Bedick - JPMorgan Jeff Rhee - Craig-Hallum Mike Cikos - Needham Tomer Zilberman - Bank of America Louie DiPalma - William Blair Operator Welcome to the Cellebrite Fourth Quarter and Full Year 2024 Financial Results Conference Call.

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate.

Company delivers “Rule of 50” Performance in 2024 with 25% ARR growth and 25% adjusted EBITDA margin Fourth-quarter 2024 revenue of $109.0 million grew 17% primarily due to 21% growth in subscription revenue ARR grew 25% to $395.9 million Fourth-quarter 2024 adjusted EBITDA of $28.8 million, 26.4% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2024.

Cellebrite's SaaS solution accelerates, expands and simplifies access to secure data collection and analysis Cellebrite's SaaS solution accelerates, expands and simplifies access to secure data collection and analysis